Speaker illustration

Professor Rongchong Huang

Beijing Friendship Hospital, Capital Medical University, Beijing (China)

Member of:

European Society of Cardiology

Rongchong Huang earned her M.D. & Ph.D. from Dalian Medical University and Fudan University, China and received training in the field of cell biology at the Burnham Institute for Medical Research in San Diego, USA. Dr. Huang was recruited to the First Hospital Affiliated to Dalian Medical University as a full Professor of Cardiology in 2010. As a trainee and visiting scientist, she went to Mayo Clinic in 2013 and continued her clinical research on shared decision making under Prof. Victor M. Montori and Prof. Henry H. Ting. Since February 2019, she became vice director and the professor of cardiology in Beijing Friendship Hospital. Huang’s Lab is focusing on the stem cell homing mechanism and immune-inflammation induced atherosclerosis. Besides of basic research, Huang’s team is the first one to perform shared-decision making in clinical research in China. As PI, she leads the team to completed five RCTs and is going on five trials in patients with coronary artery diseases.

Conversion and outcome of dual antiplatelet therapy after bleeding in patients with acute coronary syndrome

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic) ePosters


GALNT4 enhances monocyte adherence and chemotaxis by regulating PSGL1 O-glycosylation in patients with acute coronary syndrome

Event: ESC CONGRESS 2019

Topic: Leukocytes, Inflammation, Immunity

Session: Cellular mechanisms in cardiovascular inflammation


Prevalence, management strategies and outcomes of patients with coronary chronic total occlusions

Event: ESC CONGRESS 2019

Topic: Chronic Total Occlusion (CTO)

Session: High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock


The impact of thyriod hormones on the prognosis of coronary heart disease patients with subclinical hypothyroidism in SYNTAXII system

Event: ESC Congress 2018

Topic: Clinical, Other

Session: Coronary artery disease miscellaneous


This platform is supported by

logo Novo Nordisk